Article ID Journal Published Year Pages File Type
8794187 Ophthalmology 2018 16 Pages PDF
Abstract
The evidence reviewed supports DMEK as a safe and effective treatment for endothelial failure. With respect to visual recovery time, visual outcomes, and rejection rates, DMEK seems to be superior to DSEK and to induce less refractive error with similar surgical risks and EC loss compared with DSEK. The rate of air injection and repeat keratoplasty were similar in DMEK and DSEK after the learning curve for DMEK.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , ,